ACM
IDXX icon

AlphaCrest Capital Management’s Idexx Laboratories IDXX Stock Holding History

AlphaCrest Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,372
Closed -$773K – 550
2022
Q3 		$773K Sell
2,372
-4,937
-68% -$1.81M 0.05% 765
2022
Q2 		$2.56M Buy
7,309
+4,007
+121% +$1.63M 0.12% 213
2022
Q1 		$1.81M Buy
3,302
+990
+43% +$521K 0.1% 273
2021
Q4 		$1.52M Sell
2,312
-1,451
-39% -$911K 0.06% 588
2021
Q3 		$2.34M Buy
3,763
+1,659
+79% +$1.11M 0.12% 226
2021
Q2 		$1.33M Sell
2,104
-6,379
-75% -$3.52M 0.06% 529
2021
Q1 		$4.15M Buy
8,483
+6,068
+251% +$3.04M 0.23% 89
2020
Q4 		$1.21M Sell
2,415
-2,929
-55% -$1.31M 0.1% 254
2020
Q3 		$2.1M Buy
5,344
+3,011
+129% +$1.11M 0.23% 84
2020
Q2 		$770K Sell
2,333
-52
-2% -$15.1K 0.13% 217
2020
Q1 		$578K Sell
2,385
-664
-22% -$173K 0.07% 499
2019
Q4 		$796K Sell
3,049
-267
-8% -$70.4K 0.07% 483
2019
Q3 		$902K Sell
3,316
-1,287
-28% -$358K 0.05% 630
2019
Q2 		$1.27M Buy
+4,603
New +$1.13M 0.11% 294
2019
Q1 		– Sell
-1,900
Closed -$353K – 881
2018
Q4 		$353K Buy
+1,900
New +$390K 0.1% 380

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's IDXX Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 2,372 shares — an estimated $773K sold.

AlphaCrest Capital Management first reported a position in IDXX in Q4 2018 and held it in 15 quarters. The position peaked at $4.15M in Q1 2021. 1,001 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 2,372 Idexx Laboratories shares in Q4 2022, an estimated $773K.
  • AlphaCrest Capital Management first reported a position in Idexx Laboratories in Q4 2018 and held it in 15 quarters.
  • AlphaCrest Capital Management's Idexx Laboratories position peaked at $4.15M in Q1 2021.
  • 1,001 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.